Showing 91-100 of 8647 results for "".
Understanding the Signs, Symptoms, and Latest Therapeutic Recommendations for NK
https://modernod.com/cme/ophthalmology/understanding-the-signs-symptoms-and-latest-therapeutic-recommendations-for-nk/29781/Content Source This continuing education (CE/CME) activity captures content from a synchronous in-person regional meeting. Activity Description This supplement summarizes a discussion on employing classification/staging systems for neurotrophic keratitis in facilitating early diagnosis and interveDeveloping Tailored Management Strategies for DED: A Comprehensive Treatment Approach
https://modernod.com/specialty/optometry/developing-tailored-management-strategies-for-DED-a-comprehensive-treatment-approach/29822/Content Source This continuing education (CE) activity captures content from a synchronous in-person symposium. Activity Description This supplement summarizes a discussion on the importance of a healthy ocular surface, especially prior to cataract surgery, as well as the relationship between dryBe Ready When Asked, “What’s Your Specialty?”
https://modernod.com/topics/cataractrefractive-surgery/be-ready-when-asked-whats-your-specialty/39134/Trying to attract the attention of an ophthalmic practice? Specialization and passion top the list of attractive qualities.Allergy Management in Scleral Lens Wearers
https://modernod.com/topics/contact-lenses/allergy-management-in-scleral-lens-wearers/37910/Having a good baseline assessment and thorough history helps to ensure success.Researchers Tackle AMD with Hyperthermia
https://modernod.com/articles/significant-findings/researchers-tackle-amd-with-hyperthermia/48733/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuWeekly Headlines: Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-08072024/37044/Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin • Wearable Aid with AI-Powered Visual Assistant is Unveiled • ASCRS Business of Refractive Cataract Surgery Summit LaunchedOpposition Mounts Against Tariffs on Optical Products
https://modernod.com/articles/significant-findings/opposition-mounts-against-tariffs-on-optical-products/39901/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuTracking GA Development: From Initial Symptoms to Treatment Approaches
https://modernod.com/specialty/optometry/tracking-ga-development-from-initial-symptoms-to-treatment-approaches/33138/Content Source This continuing education (CE) activity captures content from a synchronous in-person symposium. Activity Description This supplement summarizes a discussion on learning how to spot progression from early/intermediate age-related macular degeneration to geographic atrophy (GA) to dTryptyr Now Available in US
https://modernod.com/podcasts/eyewire-news-the-podcast/tryptyr-now-available-in-us/37095/Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment. Learn more about your ad choices. Visit megaphone.fm/adchoicesFirst Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoices